A new cohort tretrograde study was done in USA for 20 years find increased risk for Cardiovascular
Diseases and risks in all patients with Psoriasis, Psoriatic arthritis and Rheumatoid arthritis there was better results for group of patients who received DMARDS but still the risk was high in those patients than normal population , no link proved till today about the link between
Usage of Disease modifying agents and improved CV risks and diseases but all PTs with those diseases must stop smoking ,start losing weight and keep on suitable weight and monitor good treatment for other risky factors like high cholesterol or Dyslipidemia and take aggressive treatment for Hypertension if present
We still need further studies to tackle the effect of systemic treatment for RAAnd PsA on CV risks and development
Diseases and risks in all patients with Psoriasis, Psoriatic arthritis and Rheumatoid arthritis there was better results for group of patients who received DMARDS but still the risk was high in those patients than normal population , no link proved till today about the link between
Usage of Disease modifying agents and improved CV risks and diseases but all PTs with those diseases must stop smoking ,start losing weight and keep on suitable weight and monitor good treatment for other risky factors like high cholesterol or Dyslipidemia and take aggressive treatment for Hypertension if present
We still need further studies to tackle the effect of systemic treatment for RAAnd PsA on CV risks and development
اخبار النادي الأهلي المصري اضغط هنا
معلومات طبية و دليل الأدوية اضغط هنا